Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
341 studies found for:    Central Cord Syndrome
Show Display Options
Rank Status Study
1 Unknown  Surgical Management of Spinal Cord Injuries In Neck
Conditions: Central Cord Syndrome;   Spinal Cord Injury;   Quadriparesis
Intervention: Procedure: Early and late surgery for traumatic central cord syndrome
2 Unknown  The Natural History of Traumatic Spinal Cord Injury Using fMRI, MRS and DTI
Condition: Central Cord Syndrome
Intervention:
3 Terminated Comparing Surgical Decompression Versus Conservative Treatment in Incomplete Spinal Cord Injury
Condition: Central Spinal Cord Syndrome
Interventions: Procedure: Surgical decompression;   Procedure: Conservative treatment
4 Terminated Intermittent Positive-Pressure Breathing Effects in Patients With High Spinal Cord Injury
Conditions: Central Cord Injury Syndrome;   Central Spinal Cord Syndrome
Intervention: Device: intermittent positive-pressure breathing (IPPB)
5 Completed
Has Results
Effects of Breathing and Walking Treatments on Recovery Post-Spinal Cord Injury
Conditions: Spinal Cord Injuries;   Brown Sequard;   Central Cord Syndrome
Interventions: Other: Intermittent Hypoxia;   Other: Locomotor Training
6 Unknown  Retraining Walking After Spinal Cord Injury
Conditions: Spinal Cord Injuries;   Quadriplegia;   Paraplegia;   Central Cord Syndrome;   Brown-Sequard Syndrome
Intervention: Behavioral: Locomotor treadmill training with body weight support
7 Unknown  Deep rTMS in Central Neuropathic Pain Syndromes
Conditions: Pain;   Spinal Cord Injury;   Post Stroke Pain
Intervention: Device: deep rTMS
8 Recruiting Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes
Conditions: Acute Biphenotypic Leukemia;   Acute Lymphoblastic Leukemia in Remission;   Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome;   Acute Myeloid Leukemia in Remission;   Chronic Myelogenous Leukemia, BCR-ABL1 Positive;   Mixed Phenotype Acute Leukemia;   Myelodysplastic Syndrome;   Pancytopenia;   Refractory Anemia;   Refractory Anemia With Excess Blasts;   Refractory Anemia With Excess Blasts in Transformation;   Secondary Acute Myeloid Leukemia
Interventions: Drug: Cyclophosphamide;   Drug: Cyclosporine;   Procedure: Double-Unit Umbilical Cord Blood Transplantation;   Procedure: Ex Vivo-Expanded Cord Blood Progenitor Cell Infusion;   Drug: Fludarabine Phosphate;   Other: Laboratory Biomarker Analysis;   Drug: Mycophenolate Mofetil;   Radiation: Total-Body Irradiation;   Procedure: Umbilical Cord Blood Transplantation
9 Recruiting Stem Cell Transplant Using Peripheral and Cord Blood Stem Cells to Treat Severe Aplastic Anemia and Myelopdysplastic Syndrome
Conditions: Myelodysplastic Syndrome (MDS);   Severe Aplastic Anemia (SAA)
Interventions: Other: Umbilical Cord Blood;   Other: Haploidentical Stem Cells;   Device: Miltenvi CliniMACs CD34 Reagent System
10 Terminated Erythropoietin Spinal Cord Compression Randomized Trial
Condition: Nerve Compression Syndromes
Intervention: Drug: Erythropoietin infusion
11 Completed Effect of Ropinirole on Spinal Cord Reflexes and Restless Legs Syndrome
Condition: Restless Legs Syndrome
Intervention:
12 Recruiting EEG Mapping During High Frequency/High Density Spinal Cord Stimulation in Patients With Failed Back Surgery Syndrome
Condition: Failed Back Surgery Syndrome
Intervention: Other: EEG recording + pain protocol
13 Not yet recruiting High-density in Spinal Cord Stimulation: Virtual Expert Registry
Condition: Failed Back Surgery Syndrome
Intervention: Device: spinal cord stimulation
14 Unknown  Detection of Peripheral Blood Biomarkers in Intermediate Phase Spinal Cord Injury: Correlation With Neurological and Functional Outcomes, and Comparison to Other Central and Peripheral Neurological Conditions.
Condition: Spinal Cord Injury
Intervention:
15 Unknown  Study of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood Transplantation
Conditions: Blood And Marrow Transplantation;   Leukemia;   Lymphoma;   Transplantation Infection;   Myelodysplastic Syndrome (MDS);   Non-Hodgkin's Lymphoma (NHL);   Hodgkin's Lymphoma
Interventions: Drug: Fludarabine, Clofarabine, Busulfan, ATG, TBI (Myeloablative);   Drug: Fludarabine, Melphalan, ATG (Reduced Intensity)
16 Recruiting Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Biological: filgrastim;   Drug: busulfan;   Drug: cyclosporine;   Drug: fludarabine phosphate;   Drug: melphalan;   Drug: mycophenolate mofetil;   Procedure: umbilical cord blood transplantation
17 Terminated
Has Results
Donor Umbilical Cord Blood Natural Killer Cells, Aldesleukin and Umbilical Cord Blood Transplant in Patients With Refractory Hematologic Cancers.
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Biological: aldesleukin;   Biological: filgrastim;   Biological: natural killer cell (NK) therapy;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: fludarabine phosphate;   Drug: methylprednisolone;   Drug: mycophenolate mofetil;   Procedure: Umbilical Cord Blood Transplantation (UCBT);   Radiation: Total body irradiation (TBI)
18 Completed
Has Results
Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501)
Conditions: Acute Myelogenous Leukemia;   Acute Lymphocytic Leukemia;   Chronic Myelogenous Leukemia;   Myelodysplastic Syndrome;   Natural Killer Cell Lymphoblastic Leukemia/Lymphoma
Interventions: Biological: Single Umbilical Cord Blood Unit Transplant;   Biological: Double Umbilical Cord Blood Unit Transplant;   Radiation: Total Body Irradiation;   Drug: Cyclophosphamide;   Drug: Fludarabine;   Drug: Cyclosporine A;   Drug: Mycophenolate Mofetil
19 Completed Treatment of Persistent Urinary Incontinence in Children
Condition: Urinary Incontinence
Interventions: Procedure: Surgery;   Procedure: Medical Treatment
20 Completed Cord Blood Expansion on Mesenchymal Stem Cells
Conditions: Myelodysplastic Syndrome;   Leukemia
Interventions: Procedure: Cord Blood Infusion;   Drug: Busulfan;   Drug: Fludarabine;   Drug: Rituximab;   Other: ATG;   Drug: Cyclophosphamide;   Drug: Clofarabine;   Radiation: Total Body Irradiation (TBI);   Drug: Melphalan;   Drug: Tacrolimus;   Drug: Mycophenolate Mofetil;   Drug: G-CSF

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.